Rights statement: https://www.cambridge.org/core/journals/parasitology/article/analysis-of-leishmania-mimetic-neoglycoproteins-for-the-cutaneous-leishmaniasis-diagnosis/101C72EB3721CE2245D73A580D5C17E6 The final, definitive version of this article has been published in the Journal, Parasitology, ? (?), pp ???-??? 2018, © 2018 Cambridge University Press.
Accepted author manuscript, 959 KB, PDF document
Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License
Final published version
Research output: Contribution to Journal/Magazine › Journal article › peer-review
Research output: Contribution to Journal/Magazine › Journal article › peer-review
}
TY - JOUR
T1 - Analysis of Leishmania mimetic neoglycoproteins for the cutaneous leishmaniasis diagnosis
AU - de Souza, Lígia Moraes Barizon
AU - Thomaz Soccol, Vanete
AU - Petterle, Ricardo Rasmussen
AU - Bates, Michelle D
AU - Bates, Paul A
N1 - https://www.cambridge.org/core/journals/parasitology/article/analysis-of-leishmania-mimetic-neoglycoproteins-for-the-cutaneous-leishmaniasis-diagnosis/101C72EB3721CE2245D73A580D5C17E6 The final, definitive version of this article has been published in the Journal, Parasitology, ? (?), pp ???-??? 2018, © 2018 Cambridge University Press.
PY - 2018/5/28
Y1 - 2018/5/28
N2 - Oligosaccharides are broadly present on Leishmania cell surfaces. They can be useful for the leishmaniases diagnosis and also helpful in identifying new cell markers for the disease. The disaccharide Galα1-3Galβ is the immunodominant saccharide in Leishmania cell surface and is the unique non-reducing terminal glycosphingolipids structure recognized by anti-α-Gal. This study describes an enzyme-linked immunosorbent assay (ELISA) used to measure serum levels of anti-α-galactosyl (α-Gal) antibodies in patients with cutaneous leishmaniasis (CL). Optimal ELISA conditions were established and two neoglycoproteins (NGP) containing the Galα1-3Gal terminal fraction (Galα1-3Galβ1-4GlcNAc-HAS and Galα1-3Gal-HAS) and one Galα1-3Gal NGP analogue (Galα1-3Galβ1-3GlcNAc-HAS) were used as antigens. Means of anti-α-Gal antibody titres of CL patients were significantly higher (P < 0.05) than the healthy individuals for all NGPs tested. Sensitivity and specificity of all NGPs ranged from 62.2 to 78.4% and 58.3 to 96.7%, respectively. In conclusion, the NGPs can be used for CL diagnosis.
AB - Oligosaccharides are broadly present on Leishmania cell surfaces. They can be useful for the leishmaniases diagnosis and also helpful in identifying new cell markers for the disease. The disaccharide Galα1-3Galβ is the immunodominant saccharide in Leishmania cell surface and is the unique non-reducing terminal glycosphingolipids structure recognized by anti-α-Gal. This study describes an enzyme-linked immunosorbent assay (ELISA) used to measure serum levels of anti-α-galactosyl (α-Gal) antibodies in patients with cutaneous leishmaniasis (CL). Optimal ELISA conditions were established and two neoglycoproteins (NGP) containing the Galα1-3Gal terminal fraction (Galα1-3Galβ1-4GlcNAc-HAS and Galα1-3Gal-HAS) and one Galα1-3Gal NGP analogue (Galα1-3Galβ1-3GlcNAc-HAS) were used as antigens. Means of anti-α-Gal antibody titres of CL patients were significantly higher (P < 0.05) than the healthy individuals for all NGPs tested. Sensitivity and specificity of all NGPs ranged from 62.2 to 78.4% and 58.3 to 96.7%, respectively. In conclusion, the NGPs can be used for CL diagnosis.
U2 - 10.1017/S0031182018000720
DO - 10.1017/S0031182018000720
M3 - Journal article
C2 - 29806570
JO - Parasitology
JF - Parasitology
SN - 0031-1820
ER -